2,6-二氟-苯磺酸1-甲基-3-(1-甲基-哌啶-4-基)-1H-吲哚-5-基酯 | 445441-26-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2,6-二氟-苯磺酸1-甲基-3-(1-甲基-哌啶-4-基)-1H-吲哚-5-基酯
• 英文名称: 1-methyl-3-(1-methylpiperidin-4-yl)-1H-indol-5-yl 2,6-difluorobenzenesulfonate
• 英文别名: [1-methyl-3-(1-methylpiperidin-4-yl)indol-5-yl] 2,6-difluorobenzenesulfonate
• CAS: 445441-26-9
• 化学式: C₂₁H₂₂F₂N₂O₃S
• 分子量: 420.5
• InChiKey: LYHNZWIPSZUYDT-UHFFFAOYSA-N

物化性质

• 沸点：
  565.5±50.0 °C(Predicted)
• 密度：
  1.36±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  29
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  59.9
• 氢给体数：
  0
• 氢受体数：
  6

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2933990090

文献信息

• Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor
  申请人：——

  公开号：US20040102481A1

  公开（公告）日：2004-05-27

  The present invention relates to compounds of formula I: which are antagonists of 5-HT6 receptor. 1

  本发明涉及式I的化合物：它们是5-HT6受体拮抗剂。1
• BENZENESULFONIC ACID INDOL-5-YL ESTERS AS ANTAGONISTS OF THE 5-HT6 RECEPTOR
  申请人：Filla Ann Sandra

  公开号：US20070135484A1

  公开（公告）日：2007-06-14

  The present invention relates to compounds of formula I: which are antagonists of 5-HT6 receptor.

  本发明涉及公式I的化合物：它们是5-HT6受体拮抗剂。
• Systems pharmacology for treating ocular disorders
  申请人：Case Western Reserve University

  公开号：US10117868B2

  公开（公告）日：2018-11-06

  A method of treating an ocular disorder in a subject includes administering to the subject subtherapeutic amounts of two or more agents that inhibit and/or blocks the activation of Gs- or Gq-protein coupled receptors or Gs- or Gq-signaling cascade in ocular cells of the subject, and/or activates Gi-protein coupled receptors, which is induced or triggered by light induced all-trans-retinal generation.

  一种治疗受试者眼部疾病的方法包括向受试者施用亚治疗量的两种或两种以上抑制和/或阻断受试者眼部细胞中 Gs 或 Gq 蛋白偶联受体或 Gs 或 Gq 信号级联激活的制剂，和/或激活 Gi- 蛋白偶联受体，这是由光诱导全反式视网膜生成诱导或触发的。
• Compositions and methods of treating diabetic retinopathy
  申请人：CASE WESTERN RESERVE UNIVERSITY

  公开号：US10272106B2

  公开（公告）日：2019-04-30

  A method of treating diabetic retinopathy in a subject in need thereof includes administering to the subject a therapeutically effective amount of one or more agents that act as a trap of reactive aldehydes and/or inhibit diabetes-induced superoxide generation and capillary degeneration regulated by GPCR signaling pathways.

  一种治疗糖尿病视网膜病变受试者的方法包括向受试者施用一种或多种治疗有效量的制剂，这些制剂可作为活性醛的捕获剂和/或抑制糖尿病诱导的超氧化物生成和由 GPCR 信号通路调节的毛细血管变性。
• Application of 5-HT6 receptor antagonists for the alleviation of cognitive deficits of down syndrome
  申请人：The University of Utah Research Foundation

  公开号：US10478436B2

  公开（公告）日：2019-11-19

  Methods for treating Down syndrome and improving cognitive function of a patient with an intellectual disability are disclosed. 5-hydroxytryptamine sub-receptor six (5-HT6) receptor antagonists are provided for improving the cognition of a Down syndrome patient.

  本研究公开了治疗唐氏综合症和改善智力残疾患者认知功能的方法。5-羟色胺亚受体六（5-HT6）受体拮抗剂可用于改善唐氏综合征患者的认知功能。